Article

Segment 7- Healthcare System Challenges

Panelists agreed that the cost of the new agents discussed to treat melanoma will be a challenge, just as the cost of healthcare as a whole in the United States is a major challenge.

Panelists agreed that the cost of the new agents discussed to treat melanoma will be a challenge, just as the cost of healthcare as a whole in the United States is a major challenge. Figuring out where the waste is in healthcare is difficult. “In order to ensure competition really does have these drugs available at a price that everyone has access to, we’re going to have to use tools like formularies and pathways to highlight where things are equally effective,” said Dr Malin.

Related Videos
Nini Wu, MD, Navista
John Barkett, MBA
CK Wang, MD, COTA
John Barkett, MBA
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Pieter Sonneveld, MD, PhD
Naim Alkhouri, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo